A Micro-Configured Multiparticulate Reconstitutable Suspension Powder of Fixed Dose Rifampicin and Pyrazinamide: Optimal Fabrication and In Vitro Quality Evaluation

Keyphrases

• Rifampicin 100%
• Multiparticulates 100%
• Pyrazinamide 100%
• Fixed-dose Combination 100%
• Quality Assessment 100%
• Reconstitutable 100%
• In Vitro Quality 100%
• Formulation Optimization 66%
• Dehydration 33%
• Drug Encapsulation Efficiency 33%
• Cell Viability 33%
• Biocompatibility 33%
• Drug Loading 33%
• Drug Release 33%
• Particulate 33%
• Environmentally Stable 33%
• Cytotoxicity Test 33%
• Antimycobacterial Activity 33%
• Tuberculosis Prevalence 33%
• Microscopic Examination 33%
• Pharmaceutical Formulations 33%
• Reconstitution 33%
• Organoleptic Evaluation 33%
• Re-dispersible 33%
• Age-appropriate 33%
• Flexible Dosing 33%
• Drug-excipient Interaction 33%
• Flow Properties 33%
• Oral Suspension 33%
• Manual Dynamic Agitation 33%
• Suspension Flow 33%
• Attractive Appearance 33%
• Effective Compounds 33%
• Non-Newtonian 33%
• Production Yield 33%
• Dry Powder 33%
• Zero-order Kinetic Model 33%
• High Production 33%
• Overall Rating 33%
• Mechanical Pulverization 33%
• Powder Flow 33%
• Interaction-based 33%
• Flow Quality 33%
• Characterization Experiments 33%
• Progress Management 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Rifampicin 100%
• Pyrazinamide 100%
• Prevalence 33%
• Cell Viability 33%
• Excipient 33%
• Drug Release 33%
• Antimycobacterial Agent 33%
• Microscopy 33%
• Cerebrovascular Accident 33%
• Cytotoxicity 33%